These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1106109)

  • 1. Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose.
    Bendtzen K
    Acta Allergol; 1975 Dec; 30(6):327-38. PubMed ID: 1106109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity chromatography. A new technique for partial purification of human leucocyte migration inhibitory factor.
    Bendtzen K
    J Immunol Methods; 1976; 11(2):147-51. PubMed ID: 778275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chicken buffy coat leucocytes (BCL) as indicator cells for human leucocytes migration inhibitory factor (LIF).
    Bellina L; Salerno A
    J Immunol Methods; 1981; 43(3):277-81. PubMed ID: 7019345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibition induced by MDP, LPS, PMA, and MIF/MAF: reversal by macrophage migration enhancement factor (MEF), L-fucose, L-fucosyl BSA, D-mannose, and D-mannosyl BSA.
    Gordon MR; Chida K; Takata I; Myrvik QN
    J Leukoc Biol; 1987 Sep; 42(3):197-203. PubMed ID: 3305746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-fucose, D-mannose, L-galactose, and their BSA conjugates stimulate macrophage migration.
    Takata I; Chida K; Gordon MR; Myrvik QN; Ricardo MJ; Kucera LS
    J Leukoc Biol; 1987 Mar; 41(3):248-56. PubMed ID: 3031190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibition factor (MIF): reducing the variables.
    MacSween JM; Rajaraman K; Rajaraman R; Fox RA
    J Immunol Methods; 1982; 52(1):127-36. PubMed ID: 6288804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effect of (L)-fucose binding lectin on macrophage migration inhibition caused by guinea pig migration inhibitory factor and synthetic muramyl dipeptide.
    Homma Y; Onozaki K; Hashimoto T; Miura K; Nagao S; Tanaka A
    Int Arch Allergy Appl Immunol; 1981; 65(1):27-33. PubMed ID: 7012040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
    Bendtzen K
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for alpha-L-fucose on the macrophage membrane receptor for MIF.
    Remold HG
    J Exp Med; 1973 Nov; 138(5):1065-76. PubMed ID: 4583070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correspondence between virus-induced human leukocyte interferon and concanavalin A-induced human migration inhibitory factor (MIF).
    Block LH; Cantell K; Bamberger S; Ruhenstroth-Bauer G; Strander H
    Arch Virol; 1978; 56(4):341-3. PubMed ID: 348158
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of monosaccharides in the interaction of two lymphocyte mediators with their target cells.
    Rocklin RE
    J Immunol; 1976 Mar; 116(3):816-20. PubMed ID: 768376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of macrophage migration inhibition factor by fucosylated glycolipid RM.
    Miura T; Handa S; Yamakawa T
    J Biochem; 1979 Sep; 86(3):773-6. PubMed ID: 389925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A.
    Bendtzen K; Andersen V; Bendixen G
    Acta Allergol; 1975 Jul; 30(2-3):133-49. PubMed ID: 1173991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human migration inhibitory factor: purification and immunochemical characterization.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    J Exp Med; 1978 Feb; 147(2):541-53. PubMed ID: 75241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro.
    Górski AJ; Dupont B; Hansen JA; Good RA
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3197-200. PubMed ID: 1103141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.